nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—FGFR2—skull—meningioma	0.0259	0.119	CbGeAlD
Regorafenib—DDR2—spinal cord—meningioma	0.00712	0.0327	CbGeAlD
Regorafenib—FGFR2—brainstem—meningioma	0.00585	0.0269	CbGeAlD
Regorafenib—DDR2—cerebellum—meningioma	0.00564	0.0259	CbGeAlD
Regorafenib—RAF1—brainstem—meningioma	0.00539	0.0248	CbGeAlD
Regorafenib—MAPK11—cerebellum—meningioma	0.00535	0.0246	CbGeAlD
Regorafenib—FGFR1—medulla oblongata—meningioma	0.0048	0.0221	CbGeAlD
Regorafenib—DDR2—brain—meningioma	0.00458	0.0211	CbGeAlD
Regorafenib—MAPK11—brain—meningioma	0.00434	0.02	CbGeAlD
Regorafenib—RET—medulla oblongata—meningioma	0.00429	0.0197	CbGeAlD
Regorafenib—FGFR1—spinal cord—meningioma	0.00428	0.0197	CbGeAlD
Regorafenib—KIT—brainstem—meningioma	0.00406	0.0187	CbGeAlD
Regorafenib—BRAF—cerebellum—meningioma	0.00399	0.0183	CbGeAlD
Regorafenib—TEK—medulla oblongata—meningioma	0.00391	0.018	CbGeAlD
Regorafenib—RET—spinal cord—meningioma	0.00383	0.0176	CbGeAlD
Regorafenib—EPHX2—cerebellum—meningioma	0.00381	0.0175	CbGeAlD
Regorafenib—FLT1—medulla oblongata—meningioma	0.00378	0.0174	CbGeAlD
Regorafenib—RAF1—medulla oblongata—meningioma	0.00376	0.0173	CbGeAlD
Regorafenib—FGFR2—spinal cord—meningioma	0.00364	0.0167	CbGeAlD
Regorafenib—ABL1—brainstem—meningioma	0.00354	0.0163	CbGeAlD
Regorafenib—TEK—spinal cord—meningioma	0.00349	0.016	CbGeAlD
Regorafenib—FGFR1—cerebellum—meningioma	0.00339	0.0156	CbGeAlD
Regorafenib—FLT1—spinal cord—meningioma	0.00337	0.0155	CbGeAlD
Regorafenib—RAF1—spinal cord—meningioma	0.00335	0.0154	CbGeAlD
Regorafenib—BRAF—brain—meningioma	0.00324	0.0149	CbGeAlD
Regorafenib—KDR—medulla oblongata—meningioma	0.0032	0.0147	CbGeAlD
Regorafenib—PDGFRA—spinal cord—meningioma	0.00316	0.0145	CbGeAlD
Regorafenib—EPHX2—brain—meningioma	0.0031	0.0142	CbGeAlD
Regorafenib—RET—cerebellum—meningioma	0.00303	0.014	CbGeAlD
Regorafenib—FGFR2—cerebellum—meningioma	0.00288	0.0133	CbGeAlD
Regorafenib—KDR—spinal cord—meningioma	0.00285	0.0131	CbGeAlD
Regorafenib—KIT—medulla oblongata—meningioma	0.00283	0.013	CbGeAlD
Regorafenib—FLT4—brain—meningioma	0.00279	0.0128	CbGeAlD
Regorafenib—PDGFRB—medulla oblongata—meningioma	0.00277	0.0127	CbGeAlD
Regorafenib—TEK—cerebellum—meningioma	0.00276	0.0127	CbGeAlD
Regorafenib—FGFR1—brain—meningioma	0.00275	0.0127	CbGeAlD
Regorafenib—FLT1—cerebellum—meningioma	0.00267	0.0123	CbGeAlD
Regorafenib—RAF1—cerebellum—meningioma	0.00266	0.0122	CbGeAlD
Regorafenib—KIT—spinal cord—meningioma	0.00253	0.0116	CbGeAlD
Regorafenib—PDGFRA—cerebellum—meningioma	0.0025	0.0115	CbGeAlD
Regorafenib—PDGFRB—spinal cord—meningioma	0.00247	0.0113	CbGeAlD
Regorafenib—ABL1—medulla oblongata—meningioma	0.00247	0.0113	CbGeAlD
Regorafenib—RET—brain—meningioma	0.00247	0.0113	CbGeAlD
Regorafenib—FGFR2—brain—meningioma	0.00234	0.0108	CbGeAlD
Regorafenib—EPHA2—brain—meningioma	0.0023	0.0106	CbGeAlD
Regorafenib—KDR—cerebellum—meningioma	0.00226	0.0104	CbGeAlD
Regorafenib—TEK—brain—meningioma	0.00225	0.0103	CbGeAlD
Regorafenib—ABL1—spinal cord—meningioma	0.0022	0.0101	CbGeAlD
Regorafenib—FLT1—brain—meningioma	0.00217	0.00998	CbGeAlD
Regorafenib—RAF1—brain—meningioma	0.00216	0.00992	CbGeAlD
Regorafenib—PDGFRA—brain—meningioma	0.00203	0.00935	CbGeAlD
Regorafenib—KIT—cerebellum—meningioma	0.002	0.00921	CbGeAlD
Regorafenib—PDGFRB—cerebellum—meningioma	0.00196	0.00899	CbGeAlD
Regorafenib—KDR—brain—meningioma	0.00184	0.00844	CbGeAlD
Regorafenib—ABL1—cerebellum—meningioma	0.00174	0.00801	CbGeAlD
Regorafenib—KIT—brain—meningioma	0.00163	0.00748	CbGeAlD
Regorafenib—PDGFRB—brain—meningioma	0.00159	0.0073	CbGeAlD
Regorafenib—ABCG2—medulla oblongata—meningioma	0.00155	0.00715	CbGeAlD
Regorafenib—ABL1—brain—meningioma	0.00142	0.00651	CbGeAlD
Regorafenib—ABCG2—spinal cord—meningioma	0.00139	0.00637	CbGeAlD
Regorafenib—ABCG2—cerebellum—meningioma	0.0011	0.00505	CbGeAlD
Regorafenib—CYP2C8—brain—meningioma	0.000918	0.00422	CbGeAlD
Regorafenib—ABCG2—brain—meningioma	0.000893	0.00411	CbGeAlD
Regorafenib—CYP2B6—brain—meningioma	0.000824	0.00379	CbGeAlD
Regorafenib—ABCB1—medulla oblongata—meningioma	0.000767	0.00352	CbGeAlD
Regorafenib—ABCB1—spinal cord—meningioma	0.000684	0.00314	CbGeAlD
Regorafenib—ABCB1—cerebellum—meningioma	0.000542	0.00249	CbGeAlD
Regorafenib—ABCB1—brain—meningioma	0.00044	0.00202	CbGeAlD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.00018	0.000231	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR in disease—AKT1—meningioma	0.00018	0.000231	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PGR—meningioma	0.00018	0.00023	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—ERBB2—meningioma	0.00018	0.00023	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—AKT1—meningioma	0.000179	0.000229	CbGpPWpGaD
Regorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000179	0.000229	CbGpPWpGaD
Regorafenib—FGFR2—Disease—HES1—meningioma	0.000179	0.000229	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR—AKT1—meningioma	0.000179	0.000228	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SMO—meningioma	0.000178	0.000228	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—ERBB2—meningioma	0.000178	0.000228	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SMO—meningioma	0.000178	0.000228	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—AKT1—meningioma	0.000178	0.000227	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—ERBB2—meningioma	0.000178	0.000227	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—PTEN—meningioma	0.000177	0.000227	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR in Cancer—AKT1—meningioma	0.000177	0.000226	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—ERBB2—meningioma	0.000177	0.000226	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—AKT1—meningioma	0.000176	0.000225	CbGpPWpGaD
Regorafenib—KIT—Disease—HES1—meningioma	0.000176	0.000225	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—TSHB—meningioma	0.000175	0.000224	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PGR—meningioma	0.000171	0.000219	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—ERBB2—meningioma	0.000171	0.000219	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PGR—meningioma	0.000171	0.000218	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—ERBB2—meningioma	0.000171	0.000218	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—AKT1—meningioma	0.00017	0.000218	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00017	0.000217	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALAD—meningioma	0.000169	0.000216	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HES1—meningioma	0.000168	0.000215	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TSHB—meningioma	0.000168	0.000215	CbGpPWpGaD
Regorafenib—FGFR1—Disease—HES1—meningioma	0.000167	0.000213	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—HES1—meningioma	0.000167	0.000213	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PDGFB—meningioma	0.000166	0.000212	CbGpPWpGaD
Regorafenib—BRAF—Disease—PDGFB—meningioma	0.000165	0.000211	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—AKT1—meningioma	0.000165	0.00021	CbGpPWpGaD
Regorafenib—KIT—Immune System—PDGFB—meningioma	0.000163	0.000208	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—PTEN—meningioma	0.000163	0.000208	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000163	0.000208	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—AKT1—meningioma	0.000162	0.000207	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—ERBB2—meningioma	0.000162	0.000206	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SMO—meningioma	0.00016	0.000205	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—ERBB2—meningioma	0.00016	0.000205	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—PTEN—meningioma	0.00016	0.000204	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.00016	0.000204	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HES1—meningioma	0.000159	0.000203	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—PTEN—meningioma	0.000157	0.0002	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—PTEN—meningioma	0.000156	0.0002	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—ERBB2—meningioma	0.000156	0.000199	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PDGFB—meningioma	0.000155	0.000198	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PDGFB—meningioma	0.000154	0.000197	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PGR—meningioma	0.000154	0.000196	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—ERBB2—meningioma	0.000154	0.000196	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—PTEN—meningioma	0.000154	0.000196	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—AKT1—meningioma	0.000153	0.000196	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PDGFB—meningioma	0.000153	0.000196	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—AKT1—meningioma	0.000153	0.000196	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—PTEN—meningioma	0.000152	0.000194	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—PTEN—meningioma	0.000151	0.000194	CbGpPWpGaD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000151	0.000193	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALAD—meningioma	0.000151	0.000193	CbGpPWpGaD
Regorafenib—KIT—Disease—PDGFB—meningioma	0.000151	0.000192	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—HES1—meningioma	0.00015	0.000192	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALAD—meningioma	0.000147	0.000188	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—PTEN—meningioma	0.000146	0.000186	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—PTEN—meningioma	0.000145	0.000186	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PDGFB—meningioma	0.000144	0.000184	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SMO—meningioma	0.000143	0.000183	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PDGFB—meningioma	0.000143	0.000183	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—ERBB2—meningioma	0.000143	0.000182	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PDGFB—meningioma	0.000143	0.000182	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PDGFB—meningioma	0.000139	0.000178	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000139	0.000178	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—AKT1—meningioma	0.000138	0.000176	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALAD—meningioma	0.000137	0.000176	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PGR—meningioma	0.000137	0.000175	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—ERBB2—meningioma	0.000137	0.000175	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—ERBB2—meningioma	0.000137	0.000175	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HES1—meningioma	0.000137	0.000175	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—PTEN—meningioma	0.000136	0.000174	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PDGFB—meningioma	0.000136	0.000174	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PDGFB—meningioma	0.000136	0.000173	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HES1—meningioma	0.000135	0.000173	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—AKT1—meningioma	0.000135	0.000172	CbGpPWpGaD
Regorafenib—RAF1—Disease—HES1—meningioma	0.000134	0.000171	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—PTEN—meningioma	0.000133	0.00017	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—PTEN—meningioma	0.000131	0.000167	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—TSHB—meningioma	0.000129	0.000164	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PDGFB—meningioma	0.000128	0.000164	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000126	0.000162	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HES1—meningioma	0.000126	0.00016	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PDGFB—meningioma	0.000124	0.000158	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HES1—meningioma	0.000123	0.000158	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—AKT1—meningioma	0.000123	0.000157	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—PTEN—meningioma	0.000122	0.000155	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—ERBB2—meningioma	0.000121	0.000155	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HES1—meningioma	0.000117	0.00015	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PDGFB—meningioma	0.000117	0.000149	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—PTEN—meningioma	0.000117	0.000149	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—PTEN—meningioma	0.000117	0.000149	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HES1—meningioma	0.000117	0.000149	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PDGFB—meningioma	0.000116	0.000148	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—AKT1—meningioma	0.000116	0.000148	CbGpPWpGaD
Regorafenib—RAF1—Disease—PDGFB—meningioma	0.000114	0.000146	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—ERBB2—meningioma	0.000111	0.000142	CbGpPWpGaD
Regorafenib—BRAF—Disease—ERBB2—meningioma	0.000111	0.000142	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—AKT1—meningioma	0.00011	0.00014	CbGpPWpGaD
Regorafenib—KIT—Immune System—ERBB2—meningioma	0.000109	0.00014	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—TSHB—meningioma	0.000109	0.000139	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PDGFB—meningioma	0.000107	0.000137	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TP53—meningioma	0.000107	0.000137	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PDGFB—meningioma	0.000105	0.000135	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HES1—meningioma	0.000105	0.000134	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—ERBB2—meningioma	0.000104	0.000133	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—ERBB2—meningioma	0.000103	0.000132	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PTEN—meningioma	0.000103	0.000132	CbGpPWpGaD
Regorafenib—FGFR2—Disease—ERBB2—meningioma	0.000103	0.000131	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—AKT1—meningioma	0.000102	0.000131	CbGpPWpGaD
Regorafenib—KIT—Disease—ERBB2—meningioma	0.000101	0.000129	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TP53—meningioma	0.000101	0.000129	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PDGFB—meningioma	0.0001	0.000128	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PDGFB—meningioma	9.98e-05	0.000128	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—AKT1—meningioma	9.91e-05	0.000127	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—TSHB—meningioma	9.71e-05	0.000124	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—ERBB2—meningioma	9.64e-05	0.000123	CbGpPWpGaD
Regorafenib—FGFR1—Disease—ERBB2—meningioma	9.58e-05	0.000122	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—ERBB2—meningioma	9.55e-05	0.000122	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PTEN—meningioma	9.49e-05	0.000121	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—TSHB—meningioma	9.48e-05	0.000121	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	9.48e-05	0.000121	CbGpPWpGaD
Regorafenib—BRAF—Disease—PTEN—meningioma	9.45e-05	0.000121	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—AKT1—meningioma	9.39e-05	0.00012	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HES1—meningioma	9.37e-05	0.00012	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—ERBB2—meningioma	9.32e-05	0.000119	CbGpPWpGaD
Regorafenib—KIT—Immune System—PTEN—meningioma	9.32e-05	0.000119	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—AKT1—meningioma	9.22e-05	0.000118	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TP53—meningioma	9.22e-05	0.000118	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—ERBB2—meningioma	9.11e-05	0.000116	CbGpPWpGaD
Regorafenib—ABL1—Immune System—ERBB2—meningioma	9.08e-05	0.000116	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALAD—meningioma	9.07e-05	0.000116	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—AKT1—meningioma	9.02e-05	0.000115	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—AKT1—meningioma	9.02e-05	0.000115	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PDGFB—meningioma	8.99e-05	0.000115	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—TSHB—meningioma	8.86e-05	0.000113	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—AKT1—meningioma	8.86e-05	0.000113	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PTEN—meningioma	8.85e-05	0.000113	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PTEN—meningioma	8.82e-05	0.000113	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PTEN—meningioma	8.76e-05	0.000112	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—AKT1—meningioma	8.75e-05	0.000112	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—AKT1—meningioma	8.73e-05	0.000112	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—AKT1—meningioma	8.68e-05	0.000111	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—ERBB2—meningioma	8.61e-05	0.00011	CbGpPWpGaD
Regorafenib—KIT—Disease—PTEN—meningioma	8.6e-05	0.00011	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—AKT1—meningioma	8.51e-05	0.000109	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—AKT1—meningioma	8.4e-05	0.000107	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—AKT1—meningioma	8.38e-05	0.000107	CbGpPWpGaD
Regorafenib—RAF1—Immune System—ERBB2—meningioma	8.31e-05	0.000106	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PTEN—meningioma	8.22e-05	0.000105	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PTEN—meningioma	8.17e-05	0.000104	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PTEN—meningioma	8.15e-05	0.000104	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PDGFB—meningioma	8.01e-05	0.000102	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	8e-05	0.000102	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TP53—meningioma	7.97e-05	0.000102	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PTEN—meningioma	7.95e-05	0.000102	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—AKT1—meningioma	7.94e-05	0.000101	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—AKT1—meningioma	7.86e-05	0.000101	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—ERBB2—meningioma	7.84e-05	0.0001	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—AKT1—meningioma	7.79e-05	9.95e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PTEN—meningioma	7.77e-05	9.93e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—ERBB2—meningioma	7.76e-05	9.92e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PTEN—meningioma	7.75e-05	9.9e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—ERBB2—meningioma	7.67e-05	9.8e-05	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—AKT1—meningioma	7.66e-05	9.79e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—AKT1—meningioma	7.55e-05	9.65e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTEN—meningioma	7.34e-05	9.38e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—ERBB2—meningioma	7.2e-05	9.19e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PTEN—meningioma	7.08e-05	9.05e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—ERBB2—meningioma	7.07e-05	9.03e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—AKT1—meningioma	7.01e-05	8.96e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—AKT1—meningioma	6.73e-05	8.6e-05	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—AKT1—meningioma	6.73e-05	8.6e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—ERBB2—meningioma	6.71e-05	8.57e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—ERBB2—meningioma	6.69e-05	8.55e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PTEN—meningioma	6.68e-05	8.54e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—meningioma	6.66e-05	8.51e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PTEN—meningioma	6.62e-05	8.46e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTEN—meningioma	6.54e-05	8.36e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTEN—meningioma	6.14e-05	7.84e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ERBB2—meningioma	6.03e-05	7.7e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTEN—meningioma	6.03e-05	7.7e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—AKT1—meningioma	5.96e-05	7.61e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—meningioma	5.94e-05	7.59e-05	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—AKT1—meningioma	5.92e-05	7.57e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—TSHB—meningioma	5.84e-05	7.47e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTEN—meningioma	5.72e-05	7.31e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTEN—meningioma	5.7e-05	7.29e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTEN—meningioma	5.63e-05	7.2e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTEN—meningioma	5.63e-05	7.2e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—meningioma	5.61e-05	7.17e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—AKT1—meningioma	5.47e-05	6.99e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—AKT1—meningioma	5.45e-05	6.96e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—meningioma	5.42e-05	6.92e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—AKT1—meningioma	5.37e-05	6.86e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ERBB2—meningioma	5.37e-05	6.86e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—meningioma	5.3e-05	6.78e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTEN—meningioma	5.14e-05	6.57e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—AKT1—meningioma	5.1e-05	6.51e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—AKT1—meningioma	5.08e-05	6.5e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—AKT1—meningioma	5.05e-05	6.45e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—AKT1—meningioma	4.96e-05	6.34e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTEN—meningioma	4.78e-05	6.11e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AKT1—meningioma	4.74e-05	6.06e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—AKT1—meningioma	4.71e-05	6.01e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—AKT1—meningioma	4.69e-05	6e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—AKT1—meningioma	4.58e-05	5.85e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTEN—meningioma	4.58e-05	5.85e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—meningioma	4.56e-05	5.83e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—meningioma	4.52e-05	5.77e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AKT1—meningioma	4.48e-05	5.72e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AKT1—meningioma	4.47e-05	5.71e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—AKT1—meningioma	4.46e-05	5.7e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—AKT1—meningioma	4.23e-05	5.4e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—meningioma	4.19e-05	5.35e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—meningioma	4.11e-05	5.26e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—AKT1—meningioma	4.08e-05	5.22e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—meningioma	3.9e-05	4.99e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—meningioma	3.89e-05	4.97e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AKT1—meningioma	3.85e-05	4.92e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AKT1—meningioma	3.82e-05	4.88e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—AKT1—meningioma	3.77e-05	4.82e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AKT1—meningioma	3.54e-05	4.52e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—meningioma	3.51e-05	4.48e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTEN—meningioma	3.5e-05	4.48e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AKT1—meningioma	3.47e-05	4.44e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AKT1—meningioma	3.3e-05	4.21e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AKT1—meningioma	3.29e-05	4.2e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AKT1—meningioma	3.25e-05	4.15e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AKT1—meningioma	3.25e-05	4.15e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—meningioma	3.13e-05	3.99e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTEN—meningioma	2.96e-05	3.79e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AKT1—meningioma	2.96e-05	3.78e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AKT1—meningioma	2.75e-05	3.52e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTEN—meningioma	2.65e-05	3.38e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AKT1—meningioma	2.64e-05	3.37e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTEN—meningioma	2.58e-05	3.3e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTEN—meningioma	2.41e-05	3.08e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AKT1—meningioma	2.02e-05	2.58e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AKT1—meningioma	1.71e-05	2.18e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTEN—meningioma	1.59e-05	2.03e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AKT1—meningioma	1.53e-05	1.95e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AKT1—meningioma	1.49e-05	1.9e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AKT1—meningioma	1.39e-05	1.78e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AKT1—meningioma	9.17e-06	1.17e-05	CbGpPWpGaD
